ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2708

Type 17 Immunity in Spondyloarthritis Is Expanded Across Multiple Lymphocyte Subsets

Davide Simone1, Hussein Al Mossawi1, Anna Ridley2, Jelle De Wit1, Takuya Sekine1, Nuha Ansar1, Karen Doig1 and Paul Bowness1, 1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), flow cytometry, Psoriatic arthritis and spondylarthritis, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The spondyloarthritides (SpA) are a group of chronic inflammatory disorders involving the axial spine and the peripheral joints. Genetic, functional and clinical trial evidences suggest an important role for IL17A within the context of type 17 immunity. This study aims to understand the different components of the type 17 immune axis in patients with SpA compared to healthy controls.

Methods:  Peripheral blood was obtained (with ethical approval and informed consent) from 38 patients with SpA, 17 age and sex matched healthy donors, and 14 patients with Rheumatoid Arthritis (RA) matched for CRP. Mononuclear cells were analyzed by flow cytometry using a multicolor antibody panel staining surface phenotypic markers and intracellular cytokines.

Results: Patients with SpA had a higher percentage of CD4 Th17 cells than healthy controls (mean±SD) (1.27±0.69 vs 0.67±0.41%; p<0.001). The production of IL17A in the CD8 (1.30±1.01 vs 0.40±0.45%; p<0.001) and in the γδ T cell compartment (4.86±7.04 vs 1.01±0.85%; p<0.001) was also higher in SpA than controls. Within the type 17 axis, polyfunctional cells coexpressing IL17A and GM-CSF were increased in the CD4, CD8, γδ and NK compartment in SpA, compared to healthy controls and Rheumatoid Arthritis patients (Figure 1). Analysis of the regulatory T cell pool showed a similar frequency of Tregs in the peripheral blood of SpA patients compared to healthy controls (SpA: 5.4±2.5% vs 4.7±1.9%; p=0.22), although in patients, Tregs appeared enriched in the synovial fluid compared to the peripheral blood (mean of difference±SEM: 8.8±1.3%, p<0.01).

Conclusion: Immunophenotypic analysis of the peripheral blood of SpA patients shows increased levels of type 17 immunity across multiple lymphocyte compartments, with a specific increase of polyfunctional cells coexpressing IL17A and GM-CSF. This broad skewing towards type 17 immune response in SpA supports an important role in disease.


Disclosure: D. Simone, Celgene, 2; H. Al Mossawi, None; A. Ridley, None; J. De Wit, None; T. Sekine, None; N. Ansar, None; K. Doig, None; P. Bowness, Celgene, 2.

To cite this abstract in AMA style:

Simone D, Al Mossawi H, Ridley A, De Wit J, Sekine T, Ansar N, Doig K, Bowness P. Type 17 Immunity in Spondyloarthritis Is Expanded Across Multiple Lymphocyte Subsets [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/type-17-immunity-in-spondyloarthritis-is-expanded-across-multiple-lymphocyte-subsets/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/type-17-immunity-in-spondyloarthritis-is-expanded-across-multiple-lymphocyte-subsets/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology